Novo Nordisk's Articles of Association 2023 after capital reduction, 26 April 2023
Attachment
Novo Nordisk's Articles of Association 2023 after capital reduction, 26 April 2023
Attachment
The European Medicines Agency (EMA) has issued a positive opinion for a new Wegovy® 7.2 mg dose, advancing its availability in the European Union (EU)
Read MoreNovo Nordisk and Akero Therapeutics Inc. today announced that Novo Nordisk’s acquisition of Akero, announced on 9 October 2025, has been completed
Read More